Uterine carcinosarcoma/malignant mixed Mullerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy.
10.3802/jgo.2015.26.4.249
- Author:
Brian T WILSON
1
;
Heather J CORDELL
Author Information
1. Institute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK. brian.wilson@ncl.ac.uk
- Publication Type:Brief Communication
- MeSH:
Adult;
Aged;
Aged, 80 and over;
Breast Neoplasms/*epidemiology/genetics;
Carcinosarcoma/*epidemiology/genetics;
Cohort Studies;
England/epidemiology;
Female;
Genes, BRCA1;
Genes, BRCA2;
Hormone Replacement Therapy/*statistics & numerical data;
Humans;
Incidence;
Kaplan-Meier Estimate;
Middle Aged;
Mixed Tumor, Mullerian/*epidemiology/genetics;
Mutation/genetics;
Neoplasms, Second Primary/*epidemiology;
Uterine Neoplasms/*epidemiology/genetics
- From:Journal of Gynecologic Oncology
2015;26(4):249-251
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
